Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial
1. 系统已在2026-08-25 16:24:11对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s12072-026-11093-5
文献链接: https://link.springer.com/10.1007/s12072-026-11093-5
其他信息:
出版社: Springer Science and Business Media LLC
作者: Yu Wang; Huifen Wang; Jun Cheng; Weijiang Ye; Huiguo Ding; Cunliang Deng; Guiqiang Wang; Haihang Zhu; Chengwei Chen; Guozhong Gong; Dazhi Zhang; Qing Xie; Mobin Wan; Xiong Cai; Jun Li; Qing Mao; Yongping Chen; Junqi Niu; Hao Wang; Yiming Mao; Yuwang Tian; Mingji Xian; Yuanyuan Kong; Hong Ma; Xiaojuan Ou; Jidong Jia
全文下载地址: https://link.springer.com/content/pdf/10.1007/s12072-026-11093-5.pdf
